{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:16:43Z","timestamp":1763018203680,"version":"3.37.3"},"reference-count":6,"publisher":"American Society of Hematology","issue":"13","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,7,14]]},"DOI":"10.1182\/bloodadvances.2020002346","type":"journal-article","created":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T03:48:11Z","timestamp":1593229691000},"page":"2884-2885","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":14,"title":["Navigating the narrow bridge to CAR T-cell therapy"],"prefix":"10.1182","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9106-7080","authenticated-orcid":false,"given":"Joanna C.","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, University of California San Francisco, San Francisco, CA;"},{"name":"Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4916-9857","authenticated-orcid":false,"given":"John P.","family":"Plastaras","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2020,6,26]]},"reference":[{"issue":"26","key":"2020070819495538400_B1","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N Engl J Med"},{"issue":"26","key":"2020070819495538400_B2","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa1708566","article-title":"Chimeric antigen receptor T cells in refractory B-cell lymphomas","volume":"377","author":"Schuster","year":"2017","journal-title":"N Engl J Med"},{"key":"2020070819495538400_B3","doi-asserted-by":"crossref","unstructured":"Pinnix\n              CC\n            , GuntherJR, DabajaBS, . Bridging therapy prior to axicabtagene ciloleucel for relapsed\/refractory large B-cell lymphoma. Blood Adv. 2020;4(13):2871-2883.","DOI":"10.1182\/bloodadvances.2020001837"},{"issue":"5","key":"2020070819495538400_B4","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.ijrobp.2019.05.065","article-title":"Radiation therapy as a bridging strategy for CAR T cell therapy with axicabtagene ciloleucel in diffuse large B-cell lymphoma","volume":"105","author":"Sim","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"14","key":"2020070819495538400_B5","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1182\/bloodadvances.2019000151","article-title":"Tisagenlecleucel in relapsed\/refractory diffuse large B-cell lymphoma patients without measurable disease at infusion","volume":"3","author":"Bishop","year":"2019","journal-title":"Blood Adv"},{"journal-title":"Int J Radiat Oncol Biol Phys","article-title":"Bridging radiation therapy prior to commercial chimeric antigen receptor T-cell therapy for relapsed\/refractory non-Hodgkin lymphoma [published online ahead of print 21 May 2020]","author":"Wright","key":"2020070819495538400_B6"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/13\/2884\/1748279\/advancesadv2020002346c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/13\/2884\/1748279\/advancesadv2020002346c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T23:50:04Z","timestamp":1594252204000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/4\/13\/2884\/461121\/Navigating-the-narrow-bridge-to-CAR-Tcell-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,26]]},"references-count":6,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2020,7,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2020002346","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"type":"print","value":"2473-9529"},{"type":"electronic","value":"2473-9537"}],"subject":[],"published":{"date-parts":[[2020,6,26]]}}}